Semiquantitative chest computed tomography scoring system to estimate severity in pediatric community-acquired pneumonia

QR Code

Semiquantitative chest computed tomography scoring system to estimate severity in pediatric community-acquired pneumonia

IntroductionA retrospective study assessed the utility of semiquantitative chest Computed tomography (CT) in diagnosing and determining the severity of community acquired pneumonia (CAP) in children.MethodsThe study included pediatric patients with CAP from January 2019 to December 2023. A semiquant...

Full description

Saved in:

Bibliographic Details
Main Authors:	Huifeng Fan, Xuehua Xu, Wangchun Dai, Diyuan Yang, Senqiang Zeng, Qiang Zeng, Gen Lu
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2025-08-01
Series:	Frontiers in Pediatrics
Subjects:	community-acquired pneumonia computer tomography semiquantitative evaluation score children
Online Access:	https://www.frontiersin.org/articles/10.3389/fped.2025.1556349/full
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

The Validation of Drug Resistance in Pneumonia (DRIP) Score in Predicting Infections due to Drug-Resistant Pathogens in Community-acquired Pneumonia at Cipto Mangunkusumo Hospital, Jakarta, Indonesia
by: Fadrian Fadrian, et al.
Published: (2022-01-01)

New semiquantitative parameters in digital [18F]FDG PET/CT improve diagnostic accuracy in suspected infective endocarditis
by: Carola Maria Bregenzer, et al.
Published: (2025-06-01)

Novelties in the treatment of community-acquired and hospital-acquired pneumonia
by: Matteo Bassetti, et al.
Published: (2025-04-01)

Comparative analysis of the prognostic significance of the CURB-65 and CRB-65 scores and their modifications in hospital mortality assessment in patients with community-acquired pneumonia
by: D. A. Vinokurova, et al.
Published: (2024-04-01)

Validation of Drug Resistance in Pneumonia (DRIP) Score as Empirical Antibiotic Failure Predictor in Community-Acquired Pneumonia Patients in Cipto Mangunkusumo Hospital
by: Rohayat Bilmahdi Simanjuntak, et al.
Published: (2024-04-01)

Efficacy of Scoring Systems for Routing and Predicting Length of ICU Stay in Severe Community-Acquired Pneumonia
by: Irina A. Ruslyakova, et al.
Published: (2025-02-01)

Modern characteristics of publicly acquired pneumonia caused by Clamydophyla pneumoniae
by: A. I. Danilov, et al.
Published: (2021-06-01)

Cytokine profile in community-acquired pneumonia in children
by: N. V. Iziurova, et al.
Published: (2022-11-01)

Nonlinear main components of the cytokine profile in children with community-acquired pneumonia
by: N. V. Iziurova, et al.
Published: (2024-01-01)

Real-world efficacy and safety of cefepime for pediatric community-acquired pneumonia: a propensity score-matched study
by: Changxin Liu, et al.
Published: (2025-06-01)

MULTILOCI SEQUESTERANT STRAINS OF STREPTOCOCCUS PNEUMONIAE ISOLATED FROM ELDERLY PATIENTS WITH COMMUNITY ACQUIRED PNEUMONIA
by: A. V. Martynova, et al.
Published: (2014-06-01)

The Role of Ultrasound in Diagnosing Community-Acquired Pneumonia
by: D. O. Starostin, et al.
Published: (2023-02-01)

Antibiotic Therapy of Severe Community-Acquired Pneumonia
by: O. V. Molchanova, et al.
Published: (2020-05-01)

Effects of Antibiotic De-Escalation on Outcomes in Severe Community-Acquired Pneumonia: An Inverse Propensity Score-Weighted Analysis
by: Diego Viasus, et al.
Published: (2025-07-01)

Effect of vaccination on morbidity and mortality from community-acquired pneumonia
by: T. A. Bayanova, et al.
Published: (2024-03-01)

Modern approaches at the management of children with community-acquired pneumonia
by: Aleksander A. Baranov, et al.
Published: (2023-03-01)

18F-FDG PET/CT Semiquantitative and Radiomic Features for Assessing Pathologic Axillary Lymph Node Status in Clinical Stage I–III Breast Cancer Patients: A Systematic Review
by: Anna Hwang, et al.
Published: (2025-05-01)

Role of Inflammatory Markers as a Risk Factor for Community-Acquired Pneumonia Management
by: Ruta Nutautiene, et al.
Published: (2025-06-01)

Problems of assessing the severity of the state of elderly patients with community-acquired pneumonia caused by Klebsiella pneumoniae
by: V. I. Sakharov, et al.
Published: (2020-12-01)

Combined Systemic Immune-Inflammation Index-Prognostic Nutritional Index Score in Evaluating the Prognosis of Patients with Severe Community-Acquired Pneumonia
by: Chen X, et al.
Published: (2025-05-01)

Characterization of the oxidative metabolism of erythrocytes in patients with community-acquired pneumonia
by: L. A. Demidchik, et al.
Published: (2016-05-01)

Community-acquired pneumonia: risk factors, prognosis, microbial etiology, treatment, and prophylaxis
by: Catia Cilloniz, et al.
Published: (2025-04-01)

СLINICAL AND IMMUNOLOGICAL EFFICIENCY OF IMUNOFAN AND POLYOXIDONIUM IN COMBINED THERAPY OF COMMUNITY-ACQUIRED PNEUMONIA
by: L. R. Mukhamadieva, et al.
Published: (2014-07-01)

Prognostic value of peripheral blood lymphocytes in community-acquired pneumonia in children
by: N. V. Iziurova, et al.
Published: (2025-06-01)

Discussion questions about community-acquired pneumonia in children
by: N. A. Geppe, et al.
Published: (2014-03-01)

Antibiotic Therapy of Mild Community-Acquired Pneumonia in Inpatients
by: O. V. Molchanova, et al.
Published: (2020-05-01)

Assessment of the prognosis of the outcome of severe community-acquired pneumonia caused by <i>Klebsiella pneumoniae</i>
by: V. I. Sakharov, et al.
Published: (2023-12-01)

THE ANALYSIS OF THE COMMUNITY-ACQUIRED PNEUMONIA COURSE IN CHILDREN OF ROSTOV-ON-DON
by: O. E. Semernik, et al.
Published: (2019-03-01)

Features of the clinical presentation and course of community-acquired pneumonia against the background of type 2 diabetes mellitus
by: A. A. Zaytseva, et al.
Published: (2022-07-01)

Platelet variables in community-acquired pneumonia in children with respiratory infections
by: E. A. Kozyrev, et al.
Published: (2022-04-01)

Use of medications in children hospitalized with community-acquired pneumonia
by: D. D. Siukaeva, et al.
Published: (2018-11-01)

Calculation of epidemic thresholds for incidence of community-acquired pneumonia
by: A. D. Botvinkin, et al.
Published: (2022-06-01)

Optimizing antibiotic therapy of group IV community-acquired pneumonia patients.
by: Ya. O. Dziublyk
Published: (2014-06-01)

Cytokine profile of bronchoalveolar secretion in prolonged course of community acquired pneumonia
by: R.V. Razumnyi
Published: (2022-03-01)

Inhaled Polymyxin in Treatment of Elderly Patients with Severe Community-Acquired Klebsiella pneumoniae-Induced Pneumonia
by: V. I. Sakharov, et al.
Published: (2020-12-01)

Comparative effect of immunomodulators on the contents of hydrolase inhibitors and lactoferrin in community-acquired pneumonia in adults
by: M. P. Kostinov, et al.
Published: (2020-08-01)

The Practice of Antibiotic Therapy of Severe Community-Acquired Pneumonia in Adults in Russian Multidisciplinary Hospitals
by: S. A. Rachina, et al.
Published: (2022-04-01)

Assessment of current laboratory diagnosis of pneumococcal community-acquired pneumonia
by: Е. A. Koshkarina, et al.
Published: (2020-12-01)

Substantiation of Antioxidant Drug Use for the Prevention of Community-Acquired Pneumonia in Military Personnel Serving in Conscription
by: S. A. Parfenov, et al.
Published: (2020-05-01)

Comparison of Clinical, Laboratory and Radiological Characteristics in Hospitalized Diabetic and Non Diabetic Patients with Community Acquired Pneumonia
by: Seyed Mohammad Alavi, et al.
Published: (2013-01-01)